Much of the disease nomenclature used for patients with advanced prostate cancer has negative connotations and can be confusing or intimidating. Experts in the field convened to recommend a clearer and more accurate approach to defining the nomenclature.
European urology. 2024 Oct 28 [Epub ahead of print]
William K Oh, Neeraj Agarwal, Alan Bryce, Pedro Barata, Courtney Bugler, Sigrid V Carlsson, Brad Cornell, William Dahut, Daniel George, Stacy Loeb, Bruce Montgomery, David Morris, Lorelei A Mucci, Aurelius Omlin, Ganesh Palapattu, Irbaz Bin Riaz, Charles Ryan, Martin W Schoen, Samuel L Washington, Silke Gillessen
Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: ., Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: ., Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, AZ, USA., University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Zero Prostate Cancer, Washington, DC, USA., Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden., Patient advocate., American Cancer Society, Atlanta, GA, USA., Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Department of Urology and Population Health, New York University Langone Health and Manhattan Veterans Affairs, New York, NY, USA., Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA., Urology Associates PC, Nashville, TN, USA., American Cancer Society, Atlanta, GA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Onkozentrum Zürich und Uroonkologisches Zentrum, Hirslanden Zürich, Zurich, Switzerland., Department of Urology, University of Michigan, Ann Arbor, MI, USA., Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA., Zero Prostate Cancer, Washington, DC, USA / University of Minnesota, Minneapolis, MN, USA., Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO, USA., Department of Urology, University of California-San Francisco, San Francisco, CA, USA., Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.